Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
35.02
-0.52 (-1.46%)
At close: May 9, 2025, 4:00 PM
35.02
0.00 (0.00%)
After-hours: May 9, 2025, 5:13 PM EDT

Xenon Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-234.33-182.39-125.37-78.88-28.84
Upgrade
Depreciation & Amortization
2.562.061.410.910.64
Upgrade
Other Amortization
----0.22
Upgrade
Loss (Gain) From Sale of Investments
--3.552.930.72-0
Upgrade
Stock-Based Compensation
50.7232.3720.3810.025.68
Upgrade
Other Operating Activities
-6.05-5.50.910.390.27
Upgrade
Change in Accounts Receivable
-0.610.131.76-0.46-1.03
Upgrade
Change in Accounts Payable
8.533.938.062.972.02
Upgrade
Change in Unearned Revenue
----3.64-26.81
Upgrade
Change in Other Net Operating Assets
-2.21.84-11.1-1.52-0.27
Upgrade
Operating Cash Flow
-181.39-151.11-101.03-69.5-48.12
Upgrade
Capital Expenditures
-3.08-5.62-2.89-2.05-2.64
Upgrade
Investment in Securities
168.08-105.77-290.51-244.72-14.19
Upgrade
Investing Cash Flow
165-111.39-293.41-246.77-16.82
Upgrade
Long-Term Debt Repaid
-----16.74
Upgrade
Net Debt Issued (Repaid)
-----16.74
Upgrade
Issuance of Common Stock
12.13353.52278.47447.54102.54
Upgrade
Financing Cash Flow
12.13353.52278.47447.5485.8
Upgrade
Foreign Exchange Rate Adjustments
-1.670.38-2.48-0.59-0.59
Upgrade
Net Cash Flow
-5.9391.4-118.45130.6820.25
Upgrade
Free Cash Flow
-184.46-156.73-103.92-71.55-50.76
Upgrade
Free Cash Flow Margin
---1101.57%-388.09%-157.81%
Upgrade
Free Cash Flow Per Share
-2.37-2.34-1.72-1.64-1.41
Upgrade
Cash Interest Paid
----0.34
Upgrade
Levered Free Cash Flow
-117.59-99.88-54.3-43.76-41.29
Upgrade
Unlevered Free Cash Flow
-117.59-99.88-54.3-43.76-41.2
Upgrade
Change in Net Working Capital
-6.77-5.09-7.533.2625.32
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q